These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

487 related articles for article (PubMed ID: 28770276)

  • 21. [Fluvoxamine in the treatment of depressive disorders in alcohol dependence: results of randomized open-label comparative study].
    Vinnikova MA; Severtsev VV; Komarov SD; Vdovin AS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(12):57-62. PubMed ID: 35041313
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential Associations of Specific Selective Serotonin Reuptake Inhibitors With Resting-State Heart Rate and Heart Rate Variability: Implications for Health and Well-Being.
    Kemp AH; Fráguas R; Brunoni AR; Bittencourt MS; Nunes MA; Dantas EM; Andreão RV; Mill JG; Ribeiro AL; Koenig J; Thayer JF; Benseñor IM; Lotufo PA
    Psychosom Med; 2016 Sep; 78(7):810-8. PubMed ID: 27219492
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Citalopram and cardiac toxicity.
    Cooke MJ; Waring WS
    Eur J Clin Pharmacol; 2013 Apr; 69(4):755-60. PubMed ID: 22996077
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Population pharmacokinetics and pharmacodynamics of escitalopram in overdose and the effect of activated charcoal.
    van Gorp F; Duffull S; Hackett LP; Isbister GK
    Br J Clin Pharmacol; 2012 Mar; 73(3):402-10. PubMed ID: 21883384
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Should We be Worried About QTc Prolongation Using Citalopram? A Review.
    Hutton LMJ; Cave AJ; St-Jean R; Banh HL
    J Pharm Pract; 2017 Jun; 30(3):353-358. PubMed ID: 26763342
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of activated charcoal on citalopram-induced QT prolongation.
    Greene SC; Brooks DE; Lovecchio F
    Ann Emerg Med; 2008 Jul; 52(1):86-7; author reply 87-8. PubMed ID: 18565387
    [No Abstract]   [Full Text] [Related]  

  • 27. Serious arrhythmia in initiators of citalopram, escitalopram, and other selective serotonin reuptake inhibitors: A population-based cohort study in older adults.
    Aakjaer M; Werther SK; De Bruin ML; Andersen M
    Clin Transl Sci; 2022 Sep; 15(9):2105-2115. PubMed ID: 35733364
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proton pump inhibitors may enhance the risk of citalopram- and escitalopram-associated sudden cardiac death among patients receiving hemodialysis.
    Assimon MM; Pun PH; Al-Khatib SM; Brookhart MA; Gaynes BN; Winkelmayer WC; Flythe JE
    Pharmacoepidemiol Drug Saf; 2022 Jun; 31(6):670-679. PubMed ID: 35285107
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of date of drug marketing on disproportionality measures in pharmacovigilance: the example of suicide with SSRIs using data from the UK MHRA.
    Pariente A; Daveluy A; Laribière-Bénard A; Miremont-Salame G; Begaud B; Moore N
    Drug Saf; 2009; 32(5):441-7. PubMed ID: 19419238
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Citalopram, escitalopram, and the QT interval.
    Med Lett Drugs Ther; 2013 Jul; 55(1421):59. PubMed ID: 23863918
    [No Abstract]   [Full Text] [Related]  

  • 31. [Selective serotonin reuptake inhibitors and mammary pathologies].
    Shchepotin IB; Zotov AS; Dobzhenko MN
    Vopr Onkol; 2010; 56(4):393-7. PubMed ID: 20968014
    [No Abstract]   [Full Text] [Related]  

  • 32. Activated charcoal decreases the risk of QT prolongation after citalopram overdose.
    Isbister GK; Friberg LE; Stokes B; Buckley NA; Lee C; Gunja N; Brown SG; MacDonald E; Graudins A; Holdgate A; Duffull SB
    Ann Emerg Med; 2007 Nov; 50(5):593-600, 600.e1-46. PubMed ID: 17719135
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of selective serotonin reuptake inhibitors during pregnancy and risk of major and cardiovascular malformations: an update.
    Tuccori M; Montagnani S; Testi A; Ruggiero E; Mantarro S; Scollo C; Pergola A; Fornai M; Antonioli L; Colucci R; Corona T; Blandizzi C
    Postgrad Med; 2010 Jul; 122(4):49-65. PubMed ID: 20675971
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Citalopram, QTc Prolongation, and Torsades de Pointes.
    Tampi RR; Balderas M; Carter KV; Tampi DJ; Moca M; Knudsen A; May J
    Psychosomatics; 2015; 56(1):36-43. PubMed ID: 25619672
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Citalopram, escitalopram and prolonged QT: warning or alarm?].
    Alvarez E; Vieira S; Garcia-Moll X
    Rev Psiquiatr Salud Ment; 2014; 7(3):147-50. PubMed ID: 24556340
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative cardiovascular safety of selective serotonin reuptake inhibitors (SSRIs) among Chinese senile depression patients: A network meta-analysis of randomized controlled trials.
    Guo S; Chen L; Cheng S; Xu H
    Medicine (Baltimore); 2019 May; 98(22):e15786. PubMed ID: 31145302
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical and ECG effects of escitalopram overdose.
    van Gorp F; Whyte IM; Isbister GK
    Ann Emerg Med; 2009 Sep; 54(3):404-8. PubMed ID: 19556032
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serotonin reuptake inhibitors and breastfeeding: a systematic review.
    Orsolini L; Bellantuono C
    Hum Psychopharmacol; 2015 Jan; 30(1):4-20. PubMed ID: 25572308
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparative analysis of selective serotonin reuptake inhibitors and fall risk in older adults.
    Haddad YK; Kakara R; Marcum ZA
    J Am Geriatr Soc; 2022 May; 70(5):1450-1460. PubMed ID: 35132611
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Focus on Abuse/Misuse and Withdrawal Issues with Selective Serotonin Reuptake Inhibitors (SSRIs): Analysis of Both the European EMA and the US FAERS Pharmacovigilance Databases.
    Chiappini S; Vickers-Smith R; Guirguis A; Corkery JM; Martinotti G; Schifano F
    Pharmaceuticals (Basel); 2022 May; 15(5):. PubMed ID: 35631391
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.